4.8 Article

Loss of poly(ADP-ribose) polymerase-2 leads to rapid development of spontaneous T-cell lymphomas in p53-deficient mice

期刊

ONCOGENE
卷 29, 期 19, 页码 2877-2883

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/onc.2010.11

关键词

Parp-2; p53; tumour development; thymocytes; V(D)J recombination; double-strand breaks

资金

  1. Spanish Ministerio de Ciencia e Innovacion [SAF2008-01572]
  2. Generalitat de Catalunya [2009/SGR/524]
  3. Instituto de Salud Carlos III [PI081150]
  4. Fundacion Seneca [08643/PI/08]
  5. Centre National de la Recherche Scientifique, Association pour la Recherche contre le Cancer, Electricite de France, Comite du Haut-Rhin de la Ligue Nationale Contre le Cancer and Commissariat a l'Energie Atomique
  6. Spanish Ministerio de Ciencia e Innovacion
  7. Instituto de Salud Carlos III (Madrid, Spain)
  8. FFIS (Murcia, Spain)

向作者/读者索取更多资源

Poly(ADP-ribose) polymerase-2 (Parp-2) belongs to a family of enzymes that catalyse poly(ADP-ribosyl) ation of proteins. Parp-2 deficiency in mice (Parp-2(-/-)) results in reduced thymic cellularity associated with increased apoptosis in thymocytes, defining Parp-2 as an important mediator of T-cell survival during thymopoiesis. To determine whether there is a link between Parp-2 and the p53 DNA-damage-dependent apoptotic response, we have generated Parp-2/p53-double-null mutant mice. We found that p53(-/-) backgrounds completely restored the survival and development of Parp-2(-/-) thymocytes. However, Parp-2-deficient thymocytes accumulated high levels of DNA double-strand breaks (DSB), independently of the p53 status, in line with a function of Parp-2 as a caretaker promoting genomic stability during thymocytes development. Although Parp-2(-/-) mice do not have spontaneous tumours, Parp-2 deficiency accelerated spontaneous tumour development in p53-null mice, mainly T-cell lymphomas. These data suggest a synergistic interaction between Parp-2 and p53 in tumour suppression through the role of Parp-2 in DNA-damage response and genome integrity surveillance, and point to the potential importance of examining human tumours for the status of both genes. Oncogene (2010) 29, 2877-2883; doi: 10.1038/onc.2010.11; published online 15 February 2010

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Pharmacology & Pharmacy

P2X7 receptor activation impairs antitumour activity of natural killer cells

Alberto Baroja-Mazo, Alejandro Penin-Franch, Fernando Lucas-Ruiz, Carlos De Torre-Minguela, Cristina Alarcon-Vila, Trinidad Hernandez-Caselles, Pablo Pelegrin

Summary: This study found that activation of the purinergic receptor P2X7 by extracellular ATP impairs the antitumor activity of NK cells, leading to an anergic state and reduced IFN-gamma secretion. This effect can be reversed by specific P2X7 antagonists and pretreatment with IL-2 or IL-15. Knockdown of the P2rx7 gene improved the control of tumor size by NK cells. These findings suggest that P2X7 activation plays a role in NK cell-mediated antitumor effectiveness, and modifying NK cells to lack P2X7 may enhance their antitumor capacity.

BRITISH JOURNAL OF PHARMACOLOGY (2023)

Article Surgery

Microvascular inflammation in the absence of human leukocyte antigen-donor-specific antibody and C4d: An orphan category in Banff classification with cytotoxic T and natural killer cell infiltration

Anna Buxeda, Laura Llinas-Mallol, Javier Gimeno, Dolores Redondo-Pachon, Carlos Arias-Cabrales, Carla Burballa, Adrian Puche, Miguel Lopez-Botet, Jose Yelamos, Carlos Vilches, Maarten Naesens, Maria Jose Perez-Saez, Julio Pascual, Marta Crespo

Summary: Isolated microvascular inflammation (iMVI) is a rare phenotype that cannot be classified as antibody-mediated rejection (ABMR) in recent Banff classifications because it lacks HLA donor-specific antibodies or C4d deposition. In this study, we compared peripheral blood leukocyte distribution and inflammatory infiltrates in kidney transplant biopsies among ABMR, iMVI, and normal cases. We found that iMVI had fewer lymphocytes and peripheral T cells compared to ABMR and normal cases, but more NKG2A+ NK cells. iMVI also showed decreased plasma cell infiltration and increased cytotoxic T cell infiltration compared to ABMR.

AMERICAN JOURNAL OF TRANSPLANTATION (2023)

Meeting Abstract Hematology

Subclonal KIT D816V Mutations Are Prevalent in Chronic Myelomonocytic Leukemia and Correlate with Distinct Phenotypic Features

Anthony Hunter, Hannah Newman, Eric Solary, Klaus Geissler, Laura Palomo, Lurdes Zamora, Francesc Sole, Valeria Santini, Timothy A. Graubert, Swapna Thota, Elizabeth A. Griffiths, Lisa Pleyer, Felicitas R. Thol, Rafael Bejar, Luis E. Aguirre, David A. Sallman, Andrew Kuykendall, Rami S. Komrokji, Tracy George, Eric Padron

Letter Hematology

Are the current guidelines for identification of myelodysplastic syndrome with germline predisposition strong enough?

Oriol Calvete, Julia Mestre, Arda Durmaz, Carmelo Gurnari, Jaroslaw P. Maciejewski, Francesc Sole

BRITISH JOURNAL OF HAEMATOLOGY (2023)

Article Biochemistry & Molecular Biology

Attenuation of Tumor Burden in Response to Rucaparib in Lung Adenocarcinoma: The Contribution of Oxidative Stress, Apoptosis, and DNA Damage

Maria Perez-Peiro, Paula Valenti-Serra, Blanca Leon-Gonzalez, Coral Ampurdanes, Xavier Duran, Jose Yelamos, Esther Barreiro

Summary: In this study, it was found that the PARP inhibitor rucaparib reduced tumor burden in lung adenocarcinoma in mice through multiple biological mechanisms, including apoptosis and oxidative stress. Treatment with rucaparib resulted in decreased PARP activity and cell proliferation, increased DNA damage and apoptosis, and elevated levels of protein oxidation and SOD2. These findings suggest the potential of PARP inhibitors for reducing tumor burden in lung adenocarcinoma.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Hematology

A sex-informed approach to improve the personalised decision making process in myelodysplastic syndromes: a multicentre, observational cohort study

Giulia Maggioni, Matteo Bersanelli, Erica Travaglino, Ana Alfonso Pierola, Annika Kasprzak, Arnan Sangerman Montserrat, Elisabetta Sauta, Claudia Sala, Tommaso Matteuzzi, Manja Meggendorfer, Matteo Gnocchi, Lin--Pierre Zhao, Cristina Astrid Tentori, Kathrin Nachtkamp, Daniele Dall'Olio, Ettore Mosca, Marta Ubezio, Alessia Campagna, Antonio Russo, Giulia Rivoli, Massimo Bernardi, Lorenza Borin, Maria Teresa Voso, Marta Riva, Esther Natalie Oliva, Matteo Zampini, Elena Riva, Elena Saba, Saverio D'Amico, Luca Lanino, Benedetta Tinterri, Francesca Re, Marilena Bicchieri, Laura Giordano, Giovanni Angelotti, Pierandrea Morandini, Anne Sophie Kubasch, Francesco Passamonti, Alessandro Rambaldi, Victor Savevski, Armando Santoro, Arjan A. van de Loosdrecht, Alice Brogi, Valeria Santini, Shahram Kordasti, Guillermo Sanz, Francesc Sole, Norbert Gattermann, Wolfgang Kern, Uwe Platzbecker, Lionel Ades, Pierre Fenaux, Torsten Haferlach, Gastone Castellani, Ulrich Germing, Maria Diez--Campelo, Matteo G. Della Porta

Summary: This study aimed to describe sex diversity in myelodysplastic syndromes and incorporate sex information into clinical decision-making. The study found differences between men and women in terms of disease genotype, phenotype, and clinical outcomes. Moreover, new prognostic models that included sex information were developed and performed better than the revised International Prognostic Scoring System.

LANCET HAEMATOLOGY (2023)

Article Medicine, General & Internal

Danger signals released during cold ischemia storage activate NLRP3 inflammasome in myeloid cells and influence early allograft function in liver transplantation

Fernando Lucas-Ruiz, Sandra Mateo, Marta Jover-Aguilar, Felipe Alconchel, Laura Martinez-Alarcon, Carlos De Torre-Minguela, Daniel Vidal-Correoso, Francisco Villalba-Lopez, Victor Lopez-Lopez, Antonio Rios-Zambudio, Jose A. Pons, Pablo Ramirez, Pablo Pelegrin, Alberto Baroja-Mazo

Summary: This study examined the impact of damage-associated molecular patterns (DAMPs) released during cold ischemia storage on inflammatory responses after liver transplantation. The results showed that DAMPs can induce priming and activation of the NLRP3 inflammasome in liver macrophages, leading to graft dysfunction. Inhibiting DAMPs or the NLRP3 inflammasome during cold storage may increase the success rate of liver transplantation.

EBIOMEDICINE (2023)

Article Genetics & Heredity

European standard clinical practice-Key issues for the medical care of individuals with familial leukemia

Alisa Foerster, Claudia Davenport, Nicolas Duployez, Miriam Erlacher, Alina Ferster, Jude Fitzgibbon, Gudrun Goehring, Henrik Hasle, Marjolijn C. Jongmans, Alexandra Kolenova, Geertruijte Kronnie, Tim Lammens, Cristina Mecucci, Wojciech Mlynarski, Charlotte M. Niemeyer, Francesc Sole, Tomasz Szczepanski, Esme Waanders, Andrea Biondi, Marcin Wlodarski, Brigitte Schlegelberger, Tim Ripperger

Summary: Hematologic malignancies are no longer considered sporadic and there is a need for increased awareness of familial cases. Individuals carrying a likely pathogenic germline variant are at an increased risk of developing hematologic malignancies. To ensure high-quality patient care, an European Standard Clinical Practice document has been proposed by an interdisciplinary team of experts to address key issues such as identification of individuals with familial leukemia, genetic analysis, counseling, surveillance, and support. The importance of natural history studies and registries for future evidence-based recommendations is emphasized.

EUROPEAN JOURNAL OF MEDICAL GENETICS (2023)

Article Oncology

Real-World Validation of Molecular International Prognostic Scoring System for Myelodysplastic Syndromes

Elisabetta Sauta, Marie Robin, Matteo Bersanelli, Erica Travaglino, Manja Meggendorfer, Lin-Pierre Zhao, Juan Carlos Caballero Berrocal, Claudia Sala, Giulia Maggioni, Massimo Bernardi, Carmen Di Grazia, Luca Vago, Giulia Rivoli, Lorenza Borin, Saverio D'Amico, Cristina Astrid Tentori, Marta Ubezio, Alessia Campagna, Antonio Russo, Daniele Mannina, Luca Lanino, Patrizia Chiusolo, Luisa Giaccone, Maria Teresa Voso, Marta Riva, Esther Natalie Oliva, Matteo Zampini, Elena Riva, Olivier Nibourel, Marilena Bicchieri, Niccolo' Bolli, Alessandro Rambaldi, Francesco Passamonti, Victor Savevski, Armando Santoro, Ulrich Germing, Shahram Kordasti, Valeria Santini, Maria Diez-Campelo, Guillermo Sanz, Francesc Sole, Wolfgang Kern, Uwe Platzbecker, Lionel Ades, Pierre Fenaux, Torsten Haferlach, Gastone Castellani, Matteo Giovanni Della Porta

Summary: The study validates the effectiveness of the Molecular International Prognostic Scoring System (IPSS-M) in predicting clinical outcomes of patients with myelodysplastic syndromes (MDS). IPSS-M improves the prognostic discrimination of the Revised International Prognostic Scoring System (IPSS-R) and enhances the accuracy of selecting candidates for hematopoietic stem cell transplantation (HSCT).

JOURNAL OF CLINICAL ONCOLOGY (2023)

Article Gastroenterology & Hepatology

Impact of rapid hypertrophy of tourniquet associating liver partition and portal vein ligation in the tumor progression pathways compared to two stage hepatectomy in patients with colorectal liver metastases

Victor Lopez-Lopez, Carlos Martinez-Caceres, Paula Gomez-Valles, Juan Cruz, Albert Caballero-Illanes, Roberto Brusadin, Asuncion Lopez-Conesa, Maria Perez, Kohei Miura, Jesus de la Pena-Moral, Ricardo Robles-Campos

Summary: The study suggests that liver regeneration with T-ALPPS does not lead to higher tumor progression or significant immunological changes in the tumor environment compared to classical TSH.
Article Multidisciplinary Sciences

Usefulness of PIVKA-II for monitoring after liver transplantation in patients with hepatocellular carcinoma

Francisco Villalba-Lopez, Luis Francisco Saenz-Mateos, Maria Isabel Sanchez-Lorencio, Virginia De La Orden-Garcia, Felipe Alconchel-Gago, Pedro Antonio Cascales-Campos, Carmen Garcia-Bernardo, Jose Antonio Noguera-Velasco, Alberto Baroja-Mazo, Pablo Ramirez-Romero

Summary: The study aimed to evaluate the clinical contribution of protein induced by vitamin K absence or antagonist-II (PIVKA-II) for hepatocellular carcinoma (HCC) monitoring after liver transplantation (LT) and compare it with alpha-foetoprotein (AFP). The results showed significant correlations between PIVKA-II expression levels and clinicopathological features such as tumor size and number of pre-transplant transarterial chemoembolizations (TACEs). PIVKA-II levels decreased significantly after LT and increased in patients with tumor recurrence, suggesting its potential as a novel biomarker for predicting disease severity and early recurrence.

SCIENTIFIC REPORTS (2023)

Review Oncology

The Secondary Myelodysplastic Neoplasms (MDS) Jigsaw

Oriol Calvete, Julia Mestre, Andres Jerez, Francesc Sole

Summary: The classification of secondary myelodysplastic neoplasms (MDSs) in patients with a previous primary tumor is still controversial due to the lack of an established consensus risk factor-based classification. Current classifications consider separate etiologies based on exposure to cytotoxic therapy and genetic predisposition, despite the evidence of overlapping risk factors. This review aims to summarize the current knowledge of secondary MDS etiologies and suggests the need for future classifications that take into account all risk factors and their interactions.

CANCERS (2023)

Review Gastroenterology & Hepatology

Time since liver transplant and immunosuppression withdrawal outcomes: Systematic review and individual patient data meta-analysis

Christian Appenzeller-Herzog, Aurelie Rosat, Tim Mathes, Alberto Baroja-Mazo, Andrzej Chruscinski, Sandy Feng, Ignacio Herrero, Maria-Carlota Londono, George Mazariegos, Hidenori Ohe, Jose A. Pons, Alberto Sanchez-Fueyo, Kayo Waki, Julien Vionnet

Summary: Pre-withdrawal time has a significant impact on the success or failure of immunosuppression withdrawal in liver transplant recipients, according to a systematic review and meta-analysis.

LIVER INTERNATIONAL (2023)

Article Oncology

Mutational Profile Enables the Identification of a High-Risk Subgroup in Myelodysplastic Syndromes with Isolated Trisomy 8

Sofia Toribio-Castello, Sandra Castano, Angela Villaverde-Ramiro, Esperanza Such, Montserrat Arnan, Francesc Sole, Marina Diaz-Beya, Maria Diez-Campelo, Monica del Rey, Teresa Gonzalez, Jesus Maria Hernandez-Rivas

Summary: This study found that mutations in STAG2, SRSF2 and RUNX1 are independent prognostic factors in isolated +8 MDS, defining the disease's course in terms of overall survival and leukemic transformation. These findings help identify high-risk patients and open new management possibilities for MDS patients with isolated +8.

CANCERS (2023)

Review Surgery

New challenges in cholangiocarcinoma candidates for elective surgery: harnessing the microbiome dysbiosis

Oriana Lo Re, Victor Lopez-Lopez, Andres Balaguer-Roman, Maria Antonia Martinez-Sanchez, Dilmurodjon Eshmuminov, Camilo Julio Llamoza-Torres, Kohei Miura, Alberto Baroja-Mazo, Pablo Ramirez, Ricardo Robles-Campos, Bruno Ramos-Molina

Summary: This review found that the altered microbiota composition is associated with the development of cholangiocarcinoma (CCA). Bacteria such as Helicobacter pylori, Helicobacter hepaticus, and Opisthorchis viverrini increase the risk of CCA. The most abundant genera in CCA's biliary microbiota were Enterococcus, Streptococcus, Bacteroides, Klebsiella, and Pyramidobacter. Furthermore, microbiota is related to postoperative outcomes in abdominal surgery.

LANGENBECKS ARCHIVES OF SURGERY (2023)

暂无数据